• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Joan Kennedy, president, Health Management Corporation, and senior vice president, WellPoint, Inc.

Article

Joan Kennedy's mantra is centered on empowering a multidisciplinary team of providers.

Joan Kennedy
President, Health Management Corporation (HMC)
Richmond, Va.
Senior Vice President, Wellpoint, Inc.
Indianapolis, Ind.

Prior to joining WellPoint, Kennedy served as vice president, health services for Empire, also known as WellChoice, which merged with WellPoint. She now serves as president of Health Management Corporation (HMC), a WellPoint subsidiary that provides integrated care and total population health solutions. Kennedy is responsible for growing the business 376% over three years.

To accomplish these objectives, HMC developed six pilot programs: approaches for segmenting member populations; a tool box for building a culture of health in an organization; state-of-the-art messaging targeting specific populations; use of medical monitoring devices for hypertension and diabetes; diabetes education and management; and a reduction in ethnic disparities affecting diabetes clinical outcomes.

Kennedy previously served as vice president, product development and operations for CorSolutions, a DM company. She also directed the DM and behavioral health programs for Oxford Health Plans, where she helped produce returns on investments ranging from 200% to 400%, while improving clinical outcomes and patient satisfaction.

A graduate of Bates College, where she received a B.A. degree in international relations, she also has an MBA degree from the American Graduate School of International Management. Additionally, Joan is a founding member of DMAA.

She was a 2004 Managed Healthcare Executive Leader in Disease Management.

Related Content
© 2024 MJH Life Sciences

All rights reserved.